Correlation Between BKV and CERo Therapeutics

Can any of the company-specific risk be diversified away by investing in both BKV and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BKV and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BKV Corporation and CERo Therapeutics Holdings, you can compare the effects of market volatilities on BKV and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BKV with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BKV and CERo Therapeutics.

Diversification Opportunities for BKV and CERo Therapeutics

0.63

Correlation Coefficient

BKV  CERo Therapeutics

Poor diversification

The 3 months correlation between BKV and CERo is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding BKV Corp. and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and BKV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BKV Corporation are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of BKV i.e., BKV and CERo Therapeutics go up and down completely randomly.

Pair Corralation between BKV and CERo Therapeutics

Considering the 90-day investment horizon BKV is expected to generate 8.51 times less return on investment than CERo Therapeutics. But when comparing it to its historical volatility, BKV Corporation is 17.19 times less risky than CERo Therapeutics. It trades about 0.17 of its potential returns per unit of risk. CERo Therapeutics Holdings is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  7.00  in CERo Therapeutics Holdings on September 24, 2024 and sell it today you would lose (6.10) from holding CERo Therapeutics Holdings or give up 87.14% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	38.41%
Values	Daily Returns

BKV Corp.  vs.  CERo Therapeutics Holdings

BKV Corporation

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BKV Corporation are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward-looking signals, BKV showed solid returns over the last few months and may actually be approaching a breakup point.

CERo Therapeutics

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BKV and CERo Therapeutics

The main advantage of trading using opposite BKV and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BKV position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.

The idea behind BKV Corporation and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.